- €42.34m
- €110.56m
- €229.10m
Brief: Orapi Signs Protocol For Sale Of Its Subsidiary PHEM
Brief: Orapi H1 Revenues At 117.6 Million Euros
Brief: Orapi Q1 Revenue Stable At 60.7 Million Euros
Brief: Orapi FY EBITDA Up At EUR 33.2 Mln
Brief: Orapi FY Revenue Up At 267.5 Million Euros
Brief: Orapi Q3 Revenue Up At 65.6 Million Euros
Brief: Orapi H1 EBITDA Up At 22.4 Million Euros
Brief: Orapi Applies For Listing Resumption At Euronext Paris
Brief: Orapi Announces Completion Of Financial Restructuring
Brief: Orapi Requested Trading Suspension As Of July 29
Brief: Orapi H1 Sales Up At 140.4 Million Euros
Brief: Orapi Issues New Share Subscription Warrants
Brief: ORAPI Announces Modification in Restructuring Terms
Brief: Orapi Q1 Revenue Down At 62.9 Million Euros
Brief: Orapi FY Net Loss Group Share Narrows to EUR 2.9 Million
Brief: Orapi Reaches Agreement With Its Financial Creditors
Brief: Orapi Q4 Revenue Down At 55.3 Million Euros
Brief: Orapi Q3 Revenue Stable At 56.0 Million Euros
Brief: Orapi H1 EBITDA IFRS 16 EUR 9.4 Mln, Up Versus EUR 5.5 Mln (Published) Year Ago